Perubahan Indeks Tinggi Wajah Pada Perawatan Ortodonti Maloklusi Klas I Dengan Pencabutan Empat Gigi Premolar Pertama

Lampiran 1. Alur Penelitian
SAMPEL : KASUS MALOKLUSI KLAS I BESAR SUDUT ANB 0-40
USIA 18-35 TAHUN

PENGUKURAN SEBELUM PENCABUTAN EMPAT PREMOLAR PERTAMA
1. SNA
2. SNB
3. ANB
4. PNS-ANS
5. Ar-Go
6. Me
7. FH
8. MP
PENCABUTAN EMPAT PREMOLAR PERTAMA

PENGUKURAN SETELAH PENCABUTAN
1. SNA
2. SNB
3. ANB
4. PNS-ANS
5. Ar-Go

6. Me
7. FH
8. MP
PERHITUNGAN PERUBAHAN INDEKS TINGGI WAJAH (FHI) :
TINGGI WAJAH ANTERIOR
(AFH)
TINGGI WAJAH POSTERIOR
(PFH)
SUDUT FRANKFORT MANDIBULA
(FMA)

DATA

ANALISA DATA

HASIL

Universitas Sumatera Utara

Lampiran 2. Jadwal Penelitian 2011 - 2012

Waktu Pelaksanaan (Bulan)
No

Kegiatan

7

1.
2.
3.
4.
5.
6.
7.
8.
9.

Penelusuran Kepustakaan
Persetujuan Judul
Pembuatan Proposal dan Diskusi

Seminar Proposal
Pengambilan data
Pengolahan Data
Penulisan Laporan
Seminar hasil
Perbaikan dan Penjilidan

x
x

12

1

3

4

5

6

xxxx

xxxx

x
x
xx

xxx

x
xxx

xxx

7

8

11

xxx
xxx
x
x

Universitas Sumatera Utara

Lampiran 3. Data SPSS
Paired Samples Statistics

Pair
1
Pair
2
Pair
3
Pair

4
Pair
5

AFH Pra Treatmant
AFH Pasca Treatmant
PFH Pra Treatment
PFH Pasca Treatment
FHI Pra Treatment
FHI PascaTreatment
FMA Pra Treatment
FMA Pasca Treatment
OCC Pra Treatment
OCC Pasca Treatment

Mean
70,346
71,500
54,538
56,308

,78092
,79023
26,3077
25,1154
9,1538
7,0385

N
13
13
13
13
13
13
13
13
13
13

Std. Deviation

6,8111
6,5796
5,3908
6,0880
,098681
,084039
7,19820
6,64628
6,14880
3,83222

Std. Error
Mean
1,8891
1,8249
1,4951
1,6885
,027369
,023308
1,99642

1,84335
1,70537
1,06287

Paired Samples Correlations
N
Pair
1
Pair
2
Pair
3
Pair
4
Pair
5

AFH Pra Treatmant &
AFH Pasca Treatmant
PFH Pra Treatment &

PFH Pasca Treatment
FHI Pra Treatment &
FHI PascaTreatment
FMA Pra Treatment &
FMA Pasca Treatment
OCC Pra Treatment &
OCC Pasca Treatment

Correlation

Sig.

13

,915

,000

13

,416

,157

13

,523

,067

13

,847

,000

13

,654

,015

Universitas Sumatera Utara

Pa ired Sa mples Test
Paired Differences

St d. Deviat ion

St d. E rror
Mean

-1, 1538

2,7642

,7667

-2, 8243

,5166

-1, 505

12

,158

-1, 7692

6,2304

1,7280

-5, 5342

1,9957

-1, 024

12

,326

-,009308

,090150

,025003

-,063785

,045170

-,372

12

,716

1,19231

3,86511

1,07199

-1, 14336

3,52797

1,112

12

,288

2,11538

4,65544

1,29119

-,69787

4,92864

1,638

12

,127

Mean
Pair
1
Pair
2
Pair
3
Pair
4
Pair
5

AFH P ra Treat mant AFH P asc a Treatmant
PFH P ra Treat ment PFH P asc a Treatment
FHI Pra Treatment FHI PascaTreatment
FMA P ra Treat ment FMA P asc a Treatment
OCC P ra Treat ment OCC P asc a Treatment

95% Confidenc e
Int erval of t he
Difference
Upper
Lower

t

df

Sig. (2-tailed)

Correl ations

AFH P ra Treatmant

Pearson Correlation
Sig. (2-tailed)
N
PFH P ra Treatment
Pearson Correlation
Sig. (2-tailed)
N
FHI Pra Treatment
Pearson Correlation
Sig. (2-tailed)
N
AFH P asc a Treatmant Pearson Correlation
Sig. (2-tailed)
N
PFH P asc a Treatment Pearson Correlation
Sig. (2-tailed)
N
FHI PascaTreatment
Pearson Correlation
Sig. (2-tailed)
N
FMA P ra Treat ment
Pearson Correlation
Sig. (2-tailed)
N
FMA P asc a Treatment Pearson Correlation
Sig. (2-tailed)
N
OCC P ra Treat ment
Pearson Correlation
Sig. (2-tailed)
N
OCC P asc a Treatment Pearson Correlation
Sig. (2-tailed)
N

AFH P ra
Treatmant
1
13
,141
,645
13
-,693**
,009
13
,915**
,000
13
,333
,266
13
-,457
,116
13
,625*
,022
13
,662*
,014
13
-,006
,984
13
,085
,783
13

PFH P ra
Treatment
,141
,645
13
1
13
,614*
,026
13
,184
,548
13
,416
,157
13
,231
,448
13
-,543
,055
13
-,349
,242
13
-,614*
,026
13
-,424
,149
13

FHI Pra
AFH P asc a PFH P asc a
Treatment
Treatmant
Treatment
-,693**
,915**
,333
,009
,000
,266
13
13
13
,614*
,184
,416
,026
,548
,157
13
13
13
1
-,604*
,022
,029
,944
13
13
13
-,604*
1
,399
,029
,176
13
13
13
,022
,399
1
,944
,176
13
13
13
,523
-,452
,634*
,067
,121
,020
13
13
13
-,893**
,456
-,198
,000
,118
,516
13
13
13
-,791**
,495
,066
,001
,085
,830
13
13
13
-,435
-,171
-,274
,138
,577
,365
13
13
13
-,374
-,107
-,172
,208
,727
,574
13
13
13

FHI
Pasca
Treatment
-,457
,116
13
,231
,448
13
,523
,067
13
-,452
,121
13
,634*
,020
13
1
13
-,580*
,038
13
-,347
,246
13
-,097
,752
13
-,075
,808
13

FMA P ra
FMA P asc a
OCC P ra
Treatment
Treatment
Treatment
,625*
,662*
-,006
,022
,014
,984
13
13
13
-,543
-,349
-,614*
,055
,242
,026
13
13
13
-,893**
-,791**
-,435
,000
,001
,138
13
13
13
,456
,495
-,171
,118
,085
,577
13
13
13
-,198
,066
-,274
,516
,830
,365
13
13
13
-,580*
-,347
-,097
,038
,246
,752
13
13
13
1
,847**
,540
,000
,057
13
13
13
,847**
1
,568*
,000
,043
13
13
13
,540
,568*
1
,057
,043
13
13
13
,453
,676*
,654*
,120
,011
,015
13
13
13

OCC P asc a
Treatment
,085
,783
13
-,424
,149
13
-,374
,208
13
-,107
,727
13
-,172
,574
13
-,075
,808
13
,453
,120
13
,676*
,011
13
,654*
,015
13
1
13

**. Correlation is s ignificant at the 0.01 level (2-tailed).
*. Correlation is s ignificant at the 0.05 level (2-tailed).

Universitas Sumatera Utara